Status:
COMPLETED
Psychological Impact, Mental Health and Sleep Disorder Among Patients Hospitalized and Health Care Workers During the 2019 Coronavirus Outbreak (COVID-19)
Lead Sponsor:
Murielle Surquin
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
COVID-19 is an infectious disease caused by the last coronavirus discovered, called SARS-CoV-2. Symptoms encountered in COVID-19 are: cough, breathing difficulties (dyspnea, chest pain, etc.), pyrexia...
Eligibility Criteria
Inclusion
- Subjects 65 years of age or older, having been hospitalized for COVID-19 within the CHU Brugmann Hospital
- People aged 18 or over, member of the nursing staff of the CHU Brugmann Hospital, having worked during COVID-19.
Exclusion
- Incoherent patients
- Severe presbycusis
- Oral expression impairment
- Insurmountable language barrier
Key Trial Info
Start Date :
May 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 20 2021
Estimated Enrollment :
1150 Patients enrolled
Trial Details
Trial ID
NCT04497246
Start Date
May 29 2020
End Date
August 20 2021
Last Update
April 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Brugmann
Brussels, Belgium